Patients reported significant symptom burden and daily activity impairments in the online Living With Chronic GVHD Patient Su Researchers found bronchiolitis obliterans syndrome was less frequent in HCT with HID donors compared with MSD and MUDs. Researchers found sVCAM-1 levels were higher pre- and post-HCT in patients who developed severe aGVHD. Extracellular vesicles at engraftment in hematopoietic cell transplantation may be a feasible biomarker for acute GVHD. Patients with steroid-refractory acute graft-versus-host disease who received ECP had better survival than those who did not. Investigators found greater risk for severe acute graft-versus-host disease in omitting the day 11 dose of mini-methotrexate. Mocravimod, a S1PR modulator, showed manageable safety and promising efficacy in GVHD. Leukapheresis was able to collect and store cells from patients with graft-versus-host disease for use in future trials. Vitamin D receptor deficiency appeared to play a major role in the pathology of gastrointestinal graft-versus-host disease. Elaine DeMeyer, nursing veteran, describes a live case study on the potential trauma in patients with GVHD. Oncology Nurse, Elaine DeMeyer, describes how to distinguish liver iron overload and liver graft-versus-host disease. Reduced bone marrow mesenchymal stromal cells predicted the development of acute graft-versus-host disease. Different doses of ATLG prior to HCT had a significant impact on immune reconstitution, but not GVHD outcomes. Researchers described disease and treatment trends in patients with aGVHD and highlighted the population's unmet needs. Researchers developed a diagnostic classifier that improved chronic graft-versus-host disease diagnosis in children. PTCy-based GVHD prophylaxis showed superior GRFS and OS compared with ATG-based prophylaxis in a recent study. Researchers reported that PTCy regimens led to a “low, but not negligible," incidence of chronic GVHD after haplo-HSCT. Combined reduced-dose ATG and PTCy improved GVHD outcomes compared with a standard ATG regimen. ICCGVHD score had good sensitivity, specificity, predictive value, and correlation with the 2014 NIH ocular GVHD criteria. Orca-T, an investigational allograft, reduced chronic GVHD, improved GRFS, and had manageable toxicity, according to study.